Due to the small sample size of this study, we limited the considered drugs to P-glycoprotein inhibitors, such as amiodarone, verapamil and diltiazem, that are expected to be used in combination in patients with AF and HF. This evidence concerns the gene ABCB1 and atrial fibrillation.